Fundraising Fox

BioRestorative Therapies

NASDAQ: BRTX

Melville, US · Nevada corporation

Biotech

Founders & leadership

MW
Mark WeinrebChief Executive Officer, Chairman of the Board and President
RK
Robert KristalExecutive
FS
Francisco SilvaExecutive
LA
Lance AlstodtExecutive
EL
Edward L. FieldPresident, Disc/Spine Division
MC
Mandy ClydeVice President of Operations and Secretary

Board

NV
Nickolay V KukekovBoard director
PF
Patrick F WilliamsBoard director
DA
David A RosaBoard director
PJ
Paul Jude TonnaBoard director
RB
Robert B. CatellBoard director
AJ
A. Jeffrey RadovBoard director

Reported raises · per SEC filings

Form D private placements

$16.4M disclosed across 3 rounds · 2013–2025

▶$1.4MraisedOct 2025 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nickolay V KukekovDirector
  • Robert KristalExecutive Officer
  • Francisco SilvaDirector, Executive Officer
  • Patrick F WilliamsDirector
  • David A RosaDirector
  • Lance AlstodtDirector, Executive Officer
Offering amount
$1.4M
Amount sold
$1.4M
Placement agents
Cova Capital Partners LLC
First sale
Oct 2025
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14.4MraisedMay 2016 · 81 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Edward L. FieldExecutive Officer
  • Francisco SilvaExecutive Officer
  • Paul Jude TonnaDirector
  • Robert B. CatellDirector
  • A. Jeffrey RadovDirector
  • John M. DesmaraisDirector
  • Charles S. RyanDirector
  • Mandy ClydeExecutive Officer
  • Mark WeinrebExecutive Officer, Director
Amount sold
$14.4M
Proceeds to insiders
$2.7M
First sale
Jan 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$585.8KraisedMar 2014 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mandy ClydeExecutive Officer
  • Mark WeinrebExecutive Officer, Director
  • Tommy BergerPromoter
  • Francisco SilvaExecutive Officer
  • Gloria McConnellPromoter
  • A. Jeffrey RadovDirector
  • Joel San AntonioDirector
Offering amount
$1.2M
Amount sold
$585.8K
Proceeds to insiders
$117K
First sale
Dec 2013
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$256.6K
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2021$256.6K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

BioRestorative Therapies (NASDAQ:BRTX): What Could Today's Update Reveal About Healthcare Execution?kalkinemedia.com · Aug 2026BioRestorative Therapies (NASDAQ: BRTX) adds $1M revolver and installs lender-backed directorsstocktitan.net · Jun 2026BioRestorative Therapies stock surges on activist stake By Investing.comng.investing.com · May 2026BioRestorative details BRTX-100 progress and funding | BRTX Annual Report (10-K)stocktitan.net · Mar 2026BioRestorative Therapies closes $5 million public offering By Investing.cominvesting.com · Feb 2026

Frequently asked questions

Who founded BioRestorative Therapies?
BioRestorative Therapies was founded by Mark Weinreb.
How much funding has BioRestorative Therapies raised?
BioRestorative Therapies has disclosed $16.4M raised across 3 rounds.
Where is BioRestorative Therapies headquartered?
BioRestorative Therapies is headquartered in Melville, US.